Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Oct;34(1):131–139. doi: 10.1128/iai.34.1.131-139.1981

Stimulation of human gamma interferon production by diterpene esters.

Y K Yip, R H Pang, J D Oppenheim, M S Nachbar, D Henriksen, I Zerebeckyj-Eckhardt, J Vilcek
PMCID: PMC350832  PMID: 6170583

Abstract

The diterpene ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and several structurally related compounds were tested for their ability to stimulate interferon (IFN) production in primary cultures of human leukocytes. In cultures of Ficoll-Hypaque-purified mononuclear cells, TPA treatment alone induced only low levels of IFN, but TPA pretreatment of cells caused significant enhancement of IFN yields produced with phytohemagglutinin or several other T cell mitogens. In cultures of unprocessed cells derived from plateletpheresis residues or buffy coats, TPA treatment alone induced high levels of IFN and costimulation with TPA and phytohemagglutinin produced some further enhancement of IFN production. Phorbol 12,13-dibutyrate was comparable to TPA in its ability to enhance phytohemagglutinin-induced IFN production. Several other phorbol ester analogs were also active, but maximal stimulation occurred only at higher drug concentrations. Mezerein, a structurally related diterpene ester, was at least as active as TPA in stimulating IFN production in either Ficoll-Hypaque-purified or unprocessed cells. IFN produced after stimulation with TPA or mezerein, singly or in combination with phytohemagglutinin, had several properties characteristic of IFN-gamma, e.g., it was largely inactivated by dialysis at pH 2, or after exposure to sodium dodecyl sulfate, whereas it was not neutralized by antibody to IFN-alpha and IFN-beta. The stimulatory effect of diterpene esters has proved helpful in producing IFN-gamma for physicochemical analysis and other studies.

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolf G. R., Swetly P. Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line. J Gen Virol. 1980 Nov;51(Pt 1):61–67. doi: 10.1099/0022-1317-51-1-61. [DOI] [PubMed] [Google Scholar]
  2. Allen G., Fantes K. H. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon. Nature. 1980 Oct 2;287(5781):408–411. doi: 10.1038/287408a0. [DOI] [PubMed] [Google Scholar]
  3. Crane J. L., Jr, Glasgow L. A., Kern E. R., Youngner J. S. Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. J Natl Cancer Inst. 1978 Sep;61(3):871–874. [PubMed] [Google Scholar]
  4. Dianzani F., Monahan T. M., Georgiades J., Alperin J. B. Human immune interferon: induction in lymphoid cells by a calcium ionophore. Infect Immun. 1980 Aug;29(2):561–563. doi: 10.1128/iai.29.2.561-563.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dianzani F., Monahan T. M., Scupham A., Zucca M. Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun. 1979 Dec;26(3):879–882. doi: 10.1128/iai.26.3.879-882.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dianzani F., Zucca M., Scupham A., Georgiades J. A. Immune and virus-induced interferons may activate cells by different derepressional mechanisms. Nature. 1980 Jan 24;283(5745):400–402. doi: 10.1038/283400a0. [DOI] [PubMed] [Google Scholar]
  7. Falcoff R., Oriol R., Iscaki S. Lymphocyte stimulation and interferon induction by 7 S anti-human lymphocyte globulins and their uni- and divalent fragments. Eur J Immunol. 1972 Oct;2(5):476–478. doi: 10.1002/eji.1830020520. [DOI] [PubMed] [Google Scholar]
  8. Farrar J. J., Mizel S. B., Fuller-Farrar J., Farrar W. L., Hilfiker M. L. Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. J Immunol. 1980 Aug;125(2):793–798. [PubMed] [Google Scholar]
  9. Fleischmann W. R., Jr, Kleyn K. M., Baron S. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst. 1980 Nov;65(5):963–966. [PubMed] [Google Scholar]
  10. Friedman R. M., Cooper H. L. Stimulation of interferon production in human lymphocytes by mitogens. Proc Soc Exp Biol Med. 1967 Jul;125(3):901–905. doi: 10.3181/00379727-125-32235. [DOI] [PubMed] [Google Scholar]
  11. Goeddel D. V., Leung D. W., Dull T. J., Gross M., Lawn R. M., McCandliss R., Seeburg P. H., Ullrich A., Yelverton E., Gray P. W. The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature. 1981 Mar 5;290(5801):20–26. doi: 10.1038/290020a0. [DOI] [PubMed] [Google Scholar]
  12. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Havell E. A., Vilcek J. Production of high-titered interferon in cultures of human diploid cells. Antimicrob Agents Chemother. 1972 Dec;2(6):476–484. doi: 10.1128/aac.2.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klein G., Vilcek J. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. J Gen Virol. 1980 Jan;46(1):111–117. doi: 10.1099/0022-1317-46-1-111. [DOI] [PubMed] [Google Scholar]
  15. Knight E., Jr, Hunkapiller M. W., Korant B. D., Hardy R. W., Hood L. E. Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science. 1980 Feb 1;207(4430):525–526. doi: 10.1126/science.7352259. [DOI] [PubMed] [Google Scholar]
  16. Kupchan S. M., Baxter R. L. Mezerein: antileukemic principle isolated from Daphne mezereum L. Science. 1975 Feb 21;187(4177):652–653. doi: 10.1126/science.1114315. [DOI] [PubMed] [Google Scholar]
  17. Langford M. P., Stanton G. J., Johnson H. M. Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun. 1978 Oct;22(1):62–68. doi: 10.1128/iai.22.1.62-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mastro A. M., Mueller G. C. Synergistic action of phorbol esters in mitogen-activated bovine lymphocytes. Exp Cell Res. 1974 Sep;88(1):40–46. doi: 10.1016/0014-4827(74)90615-6. [DOI] [PubMed] [Google Scholar]
  19. Mizel S. B., Rosenstreich D. L., Oppenheim J. J. Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D. Cell Immunol. 1978 Sep 15;40(1):230–235. doi: 10.1016/0008-8749(78)90330-1. [DOI] [PubMed] [Google Scholar]
  20. Mufson R. A., DeFeo D., Weinstein I. B. Effects of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts. Mol Pharmacol. 1979 Sep;16(2):569–578. [PubMed] [Google Scholar]
  21. Mufson R. A., Fischer S. M., Verma A. K., Gleason G. L., Slaga T. J., Boutwell R. K. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo. Cancer Res. 1979 Dec;39(12):4791–4795. [PubMed] [Google Scholar]
  22. Nagata S., Mantei N., Weissmann C. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature. 1980 Oct 2;287(5781):401–408. doi: 10.1038/287401a0. [DOI] [PubMed] [Google Scholar]
  23. Ratliff T. L., McCool R. E., Catalona W. J. Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A. Cell Immunol. 1981 Jan 1;57(1):1–12. doi: 10.1016/0008-8749(81)90114-3. [DOI] [PubMed] [Google Scholar]
  24. Rubin B. Y., Gupta S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928–5932. doi: 10.1073/pnas.77.10.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sehgal P. B., Sagar A. D. Heterogeneity of poly(I) x poly(C)-induced human fibroblast interferon mRNA species. Nature. 1980 Nov 6;288(5786):95–97. doi: 10.1038/288095a0. [DOI] [PubMed] [Google Scholar]
  26. Sonnenfeld G., Mandel A. D., Merigan T. C. Time and dosage dependence of immunoenhancement by murine type II interferon preparations. Cell Immunol. 1978 Oct;40(2):285–293. doi: 10.1016/0008-8749(78)90336-2. [DOI] [PubMed] [Google Scholar]
  27. Stewart W. E., 2nd, De Clercq E., De Somer P. Stabilisation of interferons by defensive reversible denaturation. Nature. 1974 May 31;249(456):460–461. doi: 10.1038/249460a0. [DOI] [PubMed] [Google Scholar]
  28. Taniguchi T., Mantei N., Schwarzstein M., Nagata S., Muramatsu M., Weissmann C. Human leukocyte and fibroblast interferons are structurally related. Nature. 1980 Jun 19;285(5766):547–549. doi: 10.1038/285547a0. [DOI] [PubMed] [Google Scholar]
  29. Taniguchi T., Pang R. H., Yip Y. K., Henriksen D., Vilcek J. Partial characterization of gamma (immune) interferon mRNA extracted from human lymphocytes. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3469–3472. doi: 10.1073/pnas.78.6.3469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Van Wauwe J. P., De Mey J. R., Goossens J. G. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol. 1980 Jun;124(6):2708–2713. [PubMed] [Google Scholar]
  31. Vilcek J., Yamazaki S., Havell E. A. Interferon induction by vesicular stomatitis virus and its role in virus replication. Infect Immun. 1977 Dec;18(3):863–865. doi: 10.1128/iai.18.3.863-865.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wang J. L., McClain D. A., Edelman G. M. Modulation of lymphocyte mitogenesis. Proc Natl Acad Sci U S A. 1975 May;72(5):1917–1921. doi: 10.1073/pnas.72.5.1917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wheelock E. F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science. 1965 Jul 16;149(3681):310–311. [PubMed] [Google Scholar]
  34. Wiranowska-Stewart M. Heterogeneity of human gamma interferon preparations: evidence for presence of alpha interferon. J Interferon Res. 1981 Feb;1(2):315–321. doi: 10.1089/jir.1981.1.315. [DOI] [PubMed] [Google Scholar]
  35. Yip Y. K., Pang R. H., Urban C., Vilcek J. Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1601–1605. doi: 10.1073/pnas.78.3.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zoon K. C., Smith M. E., Bridgen P. J., Anfinsen C. B., Hunkapiller M. W., Hood L. E. Amino terminal sequence of the major component of human lymphoblastoid interferon. Science. 1980 Feb 1;207(4430):527–528. doi: 10.1126/science.7352260. [DOI] [PubMed] [Google Scholar]
  37. de Ley M., van Damme J., Claeys H., Weening H., Heine J. W., Billiau A., Vermylen C., de Somer P. Interferon induced in human leukocytes by mitogens: production, partial purification and characterization. Eur J Immunol. 1980 Nov;10(11):877–883. doi: 10.1002/eji.1830101113. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES